NEW YORK, Oct. 7 /PRNewswire/ — Reportlinker.com announces that
a new market research report is available in its catalogue:
Merger and Acquisition Terms and Agreements in Pharma, Biotech
and Diagnostics, 4th edition
http://www.reportlinker.com/p0306576/Merger-and-Acquisition-Terms-and-Agreements-in-Pharma-Biotech-and-Diagnostics-4th-edition.html
DescriptionThe report provides a detailed understand and
analysis of how and why companies enter merger and acquisition
deals. The majority of deals are acquisitions whereby the acquirer
acquires the target company in a cash and/or equity
transaction.
Understanding the flexibility of a prospective partner’s
negotiated deals terms provides critical insight into the
negotiation process in terms of what you can expect to achieve
during the negotiation of terms. Whilst many smaller companies will
be seeking details of the payments clauses, the devil is in the
detail in terms of how payments are triggered – contract
documents provide this insight where press releases and databases
do not.
This report contains over 750 links to online copies of
actual merger and acquisition contract documents as submitted to
the Securities Exchange Commission by biopharma companies and their
partners.
Contract documents provide the answers to numerous questions
about a prospective partner’s flexibility on a wide range of
important issues, many of which will have a significant impact on
each party’s ability to derive value from the deal.
The initial chapters of this report provide an orientation of
merger and acquisition dealm
‘/>”/>
SOURCE
